Search Within

Karl Stuart Peggs

Formats
  1. Journal Article (10)
  2. Book Section (1)
Groups
  1. Department of Medicine (3)
  2. Solid Tumor Oncology Division (3)
  3. Gastrointestinal Oncology Service (2)
  4. GSK Faculty (1)
  5. Melanoma and Immunotherapeutics Service (1)
  6. Molecular Pharmacology and Chemistry Program Faculty (1)

More Groups

People
  1. James Allison (10)
  2. Sergio Quezada (6)
  3. Neil Segal (2)
  4. Tyler Simpson (2)
  5. Jelena Vider (1)
  6. Michael Curran (1)

More People

Years
  1. 2010 (1)
  2. 2009 (1)
  3. 2008 (2)
  4. 2007 (2)
  5. 2006 (4)
  6. 2005 (1)
Publications
  1. Journal of Experimental Medicine (3)
  2. Advances in Immunology (1)
  3. British Journal of Haematology (1)
  4. Cancer Cell (1)
  5. Cancer Research (1)
  6. Current Opinion in Immunology (1)

More Publications

Publishers
  1. Rockefeller University Press (3)
  2. Elsevier Inc. (2)
  3. American Association for Cancer Research (1)
  4. American Society for Clinical Investigation (1)
  5. Cell Press (1)
  6. Elsevier Science Ltd. (1)

More Publishers

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
    Journal Article

    Quezada, S. A.; Simpson, T. R.; Peggs, K. S.; Merghoub, T.; Vider, J.; Fan, X.; Blasberg, R.; Yagita, H.; Muranski, P.; Antony, P. A.; more...
    Journal of Experimental Medicine (2010)

    Fulltext@MSK | Save
  • Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
    Journal Article

    Peggs, K. S.; Quezada, S. A.; Chambers, C. A.; Korman, A. J.; Allison, J. P.
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
    Journal Article

    Quezada, S. A.; Peggs, K. S.; Simpson, T. R.; Shen, Y.; Littman, D. R.; Allison, J. P.
    Journal of Experimental Medicine (2008)

    Fulltext@MSK | Save
  • Epitope landscape in breast and colorectal cancer
    Journal Article

    Segal, N. H.; Parsons, D. W.; Peggs, K. S.; Velculescu, V.; Kinzler, K. W.; Vogelstein, B.; Allison, J. P.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Checkpoint blockade and combinatorial immunotherapies
    Book Section

    Peggs, K. S.; Quezada, S. A.; Allison, J. P.
    In Kaufman, H. L.; Wolchok, J. D. (Eds.) General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology (2007)

    Fulltext@MSK | Save
  • Targeting immunosupportive cancer therapies: Accentuate the positive, eliminate the negative
    Journal Article

    Peggs, K. S.; Segal, N. H.; Allison, J. P.
    Cancer Cell (2007)

    Fulltext@MSK | Save
  • CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
    Journal Article

    Quezada, S. A.; Peggs, K. S.; Curran, M. A.; Allison, J. P.
    Journal of Clinical Investigation (2006)

    Fulltext@MSK | Save
  • Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
    Journal Article

    Peggs, K. S.; Quezada, S. A.; Korman, A. J.; Allison, J. P.
    Current Opinion in Immunology (2006)

    Fulltext@MSK | Save
  • Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans
    Journal Article

    Peggs, K. S.
    Cytotherapy (2006)

    Fulltext@MSK | Save
  • Checkpoint blockade in cancer immunotherapy
    Journal Article

    Korman, A. J.; Peggs, K. S.; Allison, J. P.
    Advances in Immunology (2006)

    Fulltext@MSK | Save